EMD-47306

Single-particle
2.31 Å
EMD-47306 Deposition: 14/10/2024
Map released: 08/01/2025
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-47306

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9dyj summary report (pdf.gz) Map-9dyj FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BEST2 + GABA open state

EMD-47306

Single-particle
2.31 Å
EMD-47306 Deposition: 14/10/2024
Map released: 08/01/2025
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: BEST2 + GABA open state
Fitted models: 9dyj

Deposition Authors: Owji AP, Kittredge AK, Zhang Y , Yang T
Neurotransmitter-bound bestrophin channel structures reveal small molecule drug targeting sites for disease treatment.
Owji AP, Dong J, Kittredge A , Wang J , Zhang Y , Yang T
(2024) Nat Commun , 15 , 10766 - 10766
PUBMED: 39737942
DOI: doi:10.1038/s41467-024-54938-z
ISSN: 2041-1723